Celtarys

Spain Founded: 2021 • Age: 5 yrs
Company that develops and commercializes novel fluorescent probes and ligands for fluorescence-based methods in drug discovery

About Celtarys

Celtarys is a company based in Spain founded in 2021.. Celtarys offers products and services including GPCR Ligands, Adenosine Receptors, Adrenergic Receptors, and CRO Services. Celtarys operates in a competitive market with competitors including AnalytiCon Discovery, Magellan BioScience Group, C2 Pharma, BJ Biochem and Metagreen, among others.

  • Headquarter Spain
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Celtarys Research
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $81.91 K (USD), Grant

    Jul 01, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Celtarys

Celtarys offers a comprehensive portfolio of products and services, including GPCR Ligands, Adenosine Receptors, Adrenergic Receptors, and CRO Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Fluorescent ligands for high-throughput drug screening assays

Specific ligands targeting adenosine receptors in drug discovery

Ligands for adrenergic receptor studies in research applications

Custom development for drug discovery and optimization processes

People of Celtarys
Headcount 1-10
Employee Profiles 6
Employee Profiles
People
Paolo Destito
Principal Scientist
People
Alessandro Scandurra
Director of Business Development
People
Maria Majellaro
Co-founder and Chief Scientific Officer
People
Sabrina Louzán
Controller Financiero

Unlock access to complete

Funding Insights of Celtarys

  • Total Funding
  • Total Rounds 1
  • Last Round Grant — $81,911
  • First Round

    (01 Jul 2023)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2023 Amount Grant - Celtarys Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Celtarys

Celtarys has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Celtarys

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Celtarys

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Celtarys Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Celtarys

Celtarys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AnalytiCon Discovery, Magellan BioScience Group, C2 Pharma, BJ Biochem and Metagreen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Natural products chemistry is specialized in by AnalytiCon Discovery.
domain founded_year HQ Location
Identifies and develops microbial natural product leads for pharmaceutical and industrial applications
domain founded_year HQ Location
Manufactures and distributes active pharmaceutical ingredients and compounds worldwide.
domain founded_year HQ Location
Research and development services for sugar derivatives are provided.
domain founded_year HQ Location
Develops technologies to harness compounds from natural production.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Celtarys

Frequently Asked Questions about Celtarys

When was Celtarys founded?

Celtarys was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Where is Celtarys located?

Celtarys is headquartered in Spain.

What does Celtarys do?

Celtarys was founded in 2021 in Spain as a biotech company focused on research. Novel chemical tools are developed and commercialized to support fluorescence-based methods in drug discovery. Fluorescent probes are designed and synthesized for various therapeutic targets, through which drug development processes are streamlined. Operations center on advancing biomedical research tools, with applications in the pharmaceutical sector across Europe.

Who are the top competitors of Celtarys?

Celtarys's top competitors include AnalytiCon Discovery, BJ Biochem and Magellan BioScience Group.

What products or services does Celtarys offer?

Celtarys offers GPCR Ligands, Adenosine Receptors, Adrenergic Receptors, and CRO Services.

Who are Celtarys's investors?

Celtarys has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available